COLOSIGHT
DEAD

Serial Number

97119480

Owner

GENEOSCOPY, INC.

Attorney

Matthew J. Smith

Filing Date

Nov 11, 2021

Add to watchlist:

No watchlists yet
View on USPTO

COLOSIGHT Trademark

Serial Number: 97119480

COLOSIGHT is a trademark filed by GENEOSCOPY, INC. on November 11, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

GENEOSCOPY, INC. (9 trademarks)

2220 WELSCH INDUSTRIAL COURT
ST. LOUIS, MO 63146

Entity Type: 03

Geneoscopy, LLC (6 trademarks)

9300 Clayton Road
Saint Louis, MO 63124

Entity Type: 16

Trademark Details

Filing Date

November 11, 2021

Registration Date

Not Registered

Published for Opposition

October 25, 2022

Goods & Services

Diagnostic biomarkers for medical purposes for detecting cancer; Diagnostic preparations for medical purposes; biological preparations for the treatment of cancer

Compilation of information into computer databases, namely, inputting and collection of data and information in the field of cancer information for treatment and diagnostic purposes

Medical screening services in the field of cancer; Medical analysis for the diagnosis and treatment of cancer; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes in the field of cancer; Health care services, namely, for treating cancer; medical diagnosis and treatment of cancer; medical diagnosis of cancer; medical evaluation of cancer; medical services in the field of cancer; medical diagnostic services in the field of testing for cancer markers, including in a patient's excrement such as stool samples; providing a website featuring information in the field of the diagnosis and treatment of cancer; providing cancer screening services; providing information in the field of cancer prevention, screening, diagnosis and treatment; providing an on-line computer database in the field of cancer information for treatment and diagnostic purposes; providing information relating to diagnostics in the nature of medical diagnostic testing, monitoring and reporting information

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 21, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 21, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Dec 17, 2024 EX4G
SOU EXTENSION 4 FILED
Dec 16, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 16, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 12, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jun 12, 2024 EX3G
SOU EXTENSION 3 FILED
Jun 12, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2023 EXRA
SOU EXTENSION 2 GRANTED
Dec 18, 2023 EX2G
SOU EXTENSION 2 FILED
Dec 18, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 18, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 22, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jun 20, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 20, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 20, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NOAM
POST PUBLICATION AMENDMENT - ENTERED
Dec 16, 2022 CHPB
ASSIGNED TO PETITION STAFF
Dec 7, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 16, 2022 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2021 NWOS
NEW APPLICATION ENTERED
Nov 15, 2021 NWAP